Supplementary Table S1 from A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and <sup>131</sup>I in Metastatic Radioactive Iodine Refractory <i>BRAF</i> p.V600E-Mutated Differentiated Thyroid Cancer
crossref(2023)
摘要
Representativeness of Study Participants
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要